Given Imaging's PillCam ESO 3 Receives FDA Clearance

Given Imaging Ltd. GIVN today announced clearance from the U.S. Food and Drug Administration for the PillCam ESO 3 video capsule for visualizing esophageal mucosa. The clearance included a new version of RAPID® software, and the new DataRecorder 3, which includes a built-in real-time viewer. The PillCam ESO 3 capsule also incorporates many of the latest features of Given Imaging's PillCam capsule technology, including advanced electronics and optics, a wider field of view and an image capture rate of 35 frames per second. With nearly double the frame rate available in the previous generation PillCam ESO, the PillCam ESO 3 capsule enables physicians to visualize the esophagus with improved confidence.